MedPath

Registry of female precocious puberty, aiming identification of predisposing factors, optimization of treatment strategy, and elucidation of prognosis

Not Applicable
Recruiting
Conditions
female central precocious puberty
Registration Number
JPRN-UMIN000044400
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) premature thelarche 2) central precocious puberty with organic origin 3) gonadotropin-independent precocious puberty

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Information collected at the time of diagnosis: family history, maternal information during pregnancy, perinatal history, past history, social history, growth data, physical findings, endocrine test (LH, FSH, E2, DHEA-S, TSH, Free T3, Free T4, IGF-1), Bone age, ultrasonic findings of uterus and ovary, MRI findings in hypothalamo-pituitary region 2) Information collected during follow-up or treatment For non-treatment patients: growth data, physical findings, bone age (every 6 months to 1 year until menarche) For patients with LHRH analog treatment: growth data, physical findings, endocrine test, bone age, ultrasonic findings, treatment details 3) Information to be collected after the completion of treatment growth data, physical findings, endocrine tests, ultrasonography (6-months and one year following the cessation)
Secondary Outcome Measures
NameTimeMethod
Serum will be cryopreserved for each patient.
© Copyright 2025. All Rights Reserved by MedPath